The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Lung Cancer Incidence Trends by Gender, Race and Histology in the United States, 1973–2010
Open accessAbstract
BACKGROUND: Lung cancer (LC) incidence in the United States (US) continues to decrease but with significant differences by histology, gender and race. Whereas squamous, large and small cell carcinoma rates have been decreasing since the mid-80s, adenocarcinoma rates remain stable in males and continue to increase in females, with large racial disparities. We analyzed LC incidence trends by histology in the US with an emphasis on gender and racial differences. METHODS: LC incidence rates from 1973-2010 were obtained from the SEER cancer registry. Age-adjusted incidence trends of five major histological types by gender and race were evaluated using joinpoint regression. Trends of LC histology and stage distributions from 2005-2010 were analyzed. RESULTS: US LC incidence varies by histology. Squamous, large and small cell carcinoma rates continue to decrease for all gender/race combinations, whereas adenocarcinoma rates remain relatively constant in males and increasing in females. An apparent recent increase in the incidence of squamous cell carcinoma and adenocarcinoma since 2005 can be explained by a concomitant decrease in the number of cases classified as other non-small cell carcinoma. Black males continue to be disproportionally affected by squamous LCs, and blacks continue to be diagnosed with more advanced cancers than whites. CONCLUSIONS: LC incidence by histology continues to change over time. Additional variations are expected as screening becomes disseminated. It is important to continue to monitor LC rates to evaluate the impact of screening on current trends, assess the continuing benefits of tobacco control, and focus efforts on reducing racial disparities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R., Naishadham, D., & Jemal, A. (2013) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21166 · Cited by 11,825
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
The National Lung Screening Trial Research Team (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1102873 · Cited by 11,064
Permutation tests for joinpoint regression with applications to cancer rates
Kim, H.-J., Fay, M. P., Feuer, E. J., & Midthune, D. N. (2000) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(20000215)19:3<335::aid-sim336>3.0.co;2-z · Cited by 6,318
The Health consequences of smoking—50 years of progress : a report of the Surgeon General
Lushniak, B. D., Samet, J. M., Pechacek, T. F., Norman, L., & Taylor, P. A. (2014) · Cited by 4,990
Screening for Lung Cancer: U.S. Preventive Services Task Force Recommendation Statement
Moyer, V. A., & on behalf of the U.S. Preventive Services Task Force* (2014) · Annals of Internal Medicine · doi:10.7326/m13-2771 · Cited by 2,632
Govindan, R., Page, N., Morgensztern, D., Read, W., Tierney, R., Vlahiotis, A., Spitznagel, E. L., & Piccirillo, J. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.4859 · Cited by 1,845
Tanoue, L. T. (2007) · Yearbook of Medicine · doi:10.1016/s0084-3873(08)70176-7 · Cited by 1,413
Jemal, A., Simard, E. P., Dorell, C., Noone, A.-M., Markowitz, L. E., Kohler, B., Eheman, C., Saraiya, M., Bandi, P., Saslow, D., et al. (2013) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djs491 · Cited by 993
Kim, H. (2001) · Statistics in Medicine · doi:10.1002/sim.811 · Cited by 873
Ethnic and Racial Differences in the Smoking-Related Risk of Lung Cancer
Haiman, C. A., Stram, D. O., Wilkens, L. R., Pike, M. C., Kolonel, L. N., Henderson, B. E., & Le Marchand, L. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa033250 · Cited by 781
Overdiagnosis in Low-Dose Computed Tomography Screening for Lung Cancer
Patz, E. F., Pinsky, P., Gatsonis, C., Sicks, J. D., Kramer, B. S., Tammemägi, M. C., Chiles, C., Black, W. C., & Aberle, D. R. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.12738 · Cited by 776
Devesa, S. S., Bray, F., Vizcaino, A. P., & Parkin, D. M. (2005) · International Journal of Cancer · doi:10.1002/ijc.21183 · Cited by 745
Efficient interval estimation for age-adjusted cancer rates
Tiwari, R. C., Clegg, L. X., & Zou, Z. (2006) · Statistical Methods in Medical Research · doi:10.1177/0962280206070621 · Cited by 566
Cigarette smoking and lung cancer: chemical mechanisms and approaches to prevention
Hecht, S. S. (2002) · The Lancet Oncology · doi:10.1016/s1470-2045(02)00815-x · Cited by 536
Pesch, B., Kendzia, B., Gustavsson, P., Jöckel, K., Johnen, G., Pohlabeln, H., Olsson, A., Ahrens, W., Gross, I. M., Brüske, I., et al. (2012) · International Journal of Cancer · doi:10.1002/ijc.27339 · Cited by 509 · cited 1×
“Further studies characterizing differences in smoking dose response by histology, and on the associations of traditional lung cancer risk factors and other covariates with lung cancer by histological type are necessary to better understand current trends, particularly in nonsmokers [38–39].”
BackgroundCigarette Smoking and Changes in the Histopathology of Lung Cancer
Thun, M. J., Lally, C. A., Calle, E. E., Heath, C. W., Flannery, J. T., & Flanders, W. D. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.21.1580 · Cited by 500
de Koning, H. J., Meza, R., Plevritis, S. K., ten Haaf, K., Munshi, V. N., Jeon, J., Erdogan, S. A., Kong, C. Y., Han, S. S., van Rosmalen, J., et al. (2014) · Annals of Internal Medicine · doi:10.7326/m13-2316 · Cited by 466
Self-citationThe Evolving Role of Histology in the Management of Advanced Non–Small-Cell Lung Cancer
Langer, C. J., Besse, B., Gualberto, A., Brambilla, E., & Soria, J.-C. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.8126 · Cited by 300
Pinsky, P. F., Church, T. R., Izmirlian, G., & Kramer, B. S. (2013) · Cancer · doi:10.1002/cncr.28326 · Cited by 293
Comparison of aspects of smoking among the four histological types of lung cancer
Kenfield, S. A., Wei, E. K., Stampfer, M. J., Rosner, B. A., & Colditz, G. A. (2008) · Tobacco Control · doi:10.1136/tc.2007.022582 · Cited by 289
US lung cancer trends by histologic type
Lewis, D. R., Check, D. P., Caporaso, N. E., Travis, W. D., & Devesa, S. S. (2014) · Cancer · doi:10.1002/cncr.28749 · Cited by 264
Travis, W. D., Lubin, J., Ries, L., & Devesa, S. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960615)77:12<2464::aid-cncr8>3.0.co;2-m · Cited by 254
Annual number of lung cancer deaths potentially avertable by screening in the United States
Ma, J., Ward, E. M., Smith, R., & Jemal, A. (2013) · Cancer · doi:10.1002/cncr.27813 · Cited by 207
Patterns of Birth Cohort–Specific Smoking Histories, 1965–2009
Holford, T. R., Levy, D. T., McKay, L. A., Clarke, L., Racine, B., Meza, R., Land, S., Jeon, J., & Feuer, E. J. (2014) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2013.10.022 · Cited by 198
Self-citationJanssen-Heijnen, M. L. G., & Coebergh, J.-W. W. (2001) · Lung Cancer · doi:10.1016/s0169-5002(00)00197-5 · Cited by 193
Effect of Smoking Cessation on Major Histologic Types of Lung Cancer
Khuder, S., & Mutgi, A. B. (2001) · CHEST Journal · doi:10.1378/chest.120.5.1577 · Cited by 143
Development and Validation of a Lung Cancer Risk Prediction Model for African-Americans
Etzel, C. J., Kachroo, S., Liu, M., D'amelio, A. M., Dong, Q., Coté, M. L., Wenzlaff, A. S., Hong, W. K., Greisinger, A. J., Schwartz, A. G., et al. (2008) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-08-0082 · Cited by 125
Chapter 6: Lung Cancer in Never Smokers: Epidemiology and Risk Prediction Models
McCarthy, W. J., Meza, R., Jeon, J., & Moolgavkar, S. H. (2012) · Risk Analysis · doi:10.1111/j.1539-6924.2012.01768.x · Cited by 112
Self-citationDo changes in cigarette design influence the rise in adenocarcinoma of the lung?
Burns, D., Anderson, C. M., & Gray, N. J. (2010) · Cancer Causes & Control · doi:10.1007/s10552-010-9660-0 · Cited by 81
Yoshimi, I. (2003) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyg019 · Cited by 73
Pinsky, P. F. (2006) · Cancer Causes & Control · doi:10.1007/s10552-006-0038-2 · Cited by 67
Yun, Y. H., Lim, M. K., Jung, K., Bae, J., Park, S. M., Shin, S., Lee, J. S., & Park, J.-G. (2005) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0236 · Cited by 58
Conde, E., Angulo, B., Izquierdo, E., Paz-Ares, L. G., Belda-Iniesta, C., Hidalgo, M. M., & López‐Ríos, F. (2013) · Clinical & Translational Oncology · doi:10.1007/s12094-012-0983-z · Cited by 31
Andersen, B. L., & Wells, S. (2002) · Wiley eBooks · doi:10.1002/9780470693513.ch6 · Cited by 1
Cited by
The Effect of Advances in Lung-Cancer Treatment on Population Mortality
Howlader, N., Forjaz, G., Mooradian, M. J., Meza, R., Kong, C. Y., Cronin, K. A., Mariotto, A. B., Lowy, D. R., & Feuer, E. J. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1916623 · Cited by 1,712
Self-citationGlobal Epidemiology of Lung Cancer
Barta, J. A., Powell, C. A., & Wisnivesky, J. P. (2019) · Annals of Global Health · doi:10.5334/aogh.2419 · Cited by 1,575
The global burden of lung cancer: current status and future trends
Leiter, A., Veluswamy, R. R., & Wisnivesky, J. P. (2023) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-023-00798-3 · Cited by 1,477
Understanding and targeting resistance mechanisms in NSCLC
Rotow, J., & Bivona, T. G. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.84 · Cited by 972
The International Epidemiology of Lung Cancer: Latest Trends, Disparities, and Tumor Characteristics
Cheng, T.-Y. D., Cramb, S. M., Baade, P. D., Youlden, D. R., Nwogu, C., & Reid, M. E. (2016) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2016.05.021 · Cited by 600
Metadata
- Authors
- Meza, R., Meernik, C., Jeon, J., & Cote, M. L.
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2015-03-30
- Volume
- 10
- Issue
- 3
- Pages
- e0121323
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2010596067
- Cited by
- 363
- References
- 35
- FWCI
- 11.05
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.